Related Experiment Video
Updated: Jan 27, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Hydroxyurea use among children with sickle cell anemia
Sarah L Reeves1,2, Hannah K Jary1, Jennifer P Gondhi1
1Susan B Meister Child Health Evaluation and Research Center, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.
Insights
Hydroxyurea adherence is low for children with sickle cell anemia (SCA), with only 18% receiving adequate medication days. Strategies are needed to improve hydroxyurea use in pediatric SCA patients.
Area of Science:
- Pediatric Hematology
- Public Health
- Pharmacotherapy
Background:
- Sickle cell anemia (SCA) is a serious inherited blood disorder.
- Hydroxyurea is a recommended treatment for pediatric SCA.
- Adherence to hydroxyurea therapy is crucial for managing SCA complications.
Purpose of the Study:
- To assess hydroxyurea dispensing patterns in children with SCA.
- To evaluate adherence to hydroxyurea therapy based on dispensed days.
- To identify variations in hydroxyurea use across states.
Main Methods:
- Retrospective analysis of administrative claims data.
- Study population: 7963 children (ages 1-17) with SCA enrolled in Medicaid in six states (2005-2012).
- Hydroxyurea dispensing data summarized by state and year.
Main Results:
- A total of 22,424 person-years were analyzed.
- Among children receiving hydroxyurea for >30 days, only 18% received ≥300 days of supply.
- Significant state-level variation in hydroxyurea dispensing was observed.
Conclusions:
- Current hydroxyurea adherence among pediatric SCA patients is suboptimal.
- Updated recommendations emphasize offering hydroxyurea to all children with SCA.
- Development of targeted strategies is necessary to improve hydroxyurea adherence in this population.
Abstract:
This study describes hydroxyurea use among children ages 1 to 17 with sickle cell anemia (SCA) enrolled in at least one year of Medicaid in six states from 2005 to 2012. Administrative claims were used to summarize the number of days' supply of hydroxyurea dispensed by state and year. A total of 7963 children with SCA contributed 22 424 person-years. Among person-years with greater than 30 days of hydroxyurea, only 18% received at least 300 days of hydroxyurea, which varied by state. Following updated recommendations for all children with SCA to be offered hydroxyurea, strategies to increase hydroxyurea adherence among this population are needed.
More Related Videos
Related Concept Videos
Drug Dosing: Infants and Children
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Multiple Allele Traits
What are Cells?
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...
Concentration Cells
Consider the following voltaic cell:
What is Cell Signaling?

